Market Place
Sourcing Support
Silexion`s Systemic Delivery Breakthrough Boosts Precision Oncology
29 Jan 2025 //
BUSINESSWIRE
Silexion Announces Exercise of Warrants for 3.3 M Gross Proceeds
29 Jan 2025 //
GLOBENEWSWIRE
Silexion SIL-204 Reduces Tumor Growth In Pancreatic Cancer Model
28 Jan 2025 //
GLOBENEWSWIRE
Silexion Reports Strong Results For Pancreatic Cancer Treatment
15 Jan 2025 //
GLOBENEWSWIRE
Silexion Therapeutics Announces Pricing of $5.0 M Public Offering
15 Jan 2025 //
GLOBENEWSWIRE
Silexion To Present SIL-204 Data In KRAS Pancreatic Cancer At ASCO
13 Jan 2025 //
GLOBENEWSWIRE
Silexion Partners with Evonik on siRNA Formulation Development
17 Dec 2024 //
GLOBENEWSWIRE
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
22 Nov 2024 //
GLOBENEWSWIRE
Silexion Therapeutics To Present At Noble Capital Markets Conference
20 Nov 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.